I. Canadas

发表

Molecular and Genomic Determinants of Response to Immune Checkpoint Inhibition in Cancer.

Rohit Thummalapalli, Jacob Carter, D. Barbie, 2018, Annual review of medicine.

The long and short non-coding RNAs modulating EZH2 signaling in cancer

Yuzhuo Wang, F. Crea, M. Ashrafizadeh, 2022, Journal of Hematology & Oncology.

The long and short non-coding RNAs modulating EZH2 signaling in cancer

Yuzhuo Wang, F. Crea, M. Ashrafizadeh, 2022, Journal of Hematology & Oncology.

Intrinsic immunogenicity of small cell lung carcinoma revealed by its cellular plasticity.

C. Paweletz, M. Tolstorukov, E. V. Van Allen, 2021, Cancer discovery.

Autophagy Inhibition Dysregulates TBK1 Signaling and Promotes Pancreatic Inflammation

Kwok-Kin Wong, E. Oki, S. Ogino, 2016, Cancer Immunology Research.

Cytogenetic characterization of NCI-H69 and NCI-H69AR small cell lung cancer cell lines by spectral karyotyping.

S. Serrano, F. Solé, M. Salido, 2009, Cancer genetics and cytogenetics.

Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence

Henry W. Long, James M. McFarland, Zandra V. Ho, 2021, Nature Genetics.

3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockade.

Roger D Kamm, Valeria Chiono, Amir R Aref, 2018, Lab on a chip.

Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses

P. Tamayo, C. Paweletz, Kwok-Kin Wong, 2018, Nature Medicine.

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

Zhi Wei, Hongye Liu, Wei Huang, 2018, Cancer discovery.

Genetic changes in small cell lung carcinoma

F. Rojo, J. Albanell, A. Rovira, 2008, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Increased ALK Gene Copy Number and Amplification are Frequent in Non-small Cell Lung Cancer

S. Serrano, M. Salido, F. Hirsch, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC)

S. Serrano, M. Salido, J. Albanell, 2015, Oncotarget.

Organoid Culture: Applications in Development and Cancer

D. Barbie, I. Canadas, 2017 .

EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer

Henry W. Long, M. Loda, A. Kibel, 2021, Nature Cancer.

MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines

S. Serrano, M. Salido, F. Hirsch, 2011, British Journal of Cancer.

C-MET as a new therapeutic target for the development of novel anticancer drugs

F. Rojo, J. Albanell, M. Arumí-Uría, 2010, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer

M. Salido, A. Bardelli, J. Albanell, 2015, Clinical Cancer Research.

Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients

S. Serrano, F. Rojo, J. Albanell, 2010, British Journal of Cancer.

Tumor-Derived cGAMP Regulates Activation of the Vasculature

C. Paweletz, R. Kamm, V. Chiono, 2020, Frontiers in Immunology.

Activation of tumor-cell STING primes NK-cell therapy.

C. Paweletz, M. Tolstorukov, W. Richards, 2022, Cancer immunology research.

Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer

M. Salido, F. Rojo, J. Albanell, 2013, Clinical Cancer Research.

Angiopoietin-2 is a negative prognostic marker in small cell lung cancer.

F. Rojo, J. Albanell, O. Arpí, 2015, Lung cancer.

MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer

C. Paweletz, P. Janne, P. Lizotte, 2022, Cancer research.

High circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patients

F. Rojo, J. Albanell, O. Arpí, 2014, Oncotarget.

The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer

A. Bardelli, J. Albanell, J. Tabernero, 2016, Clinical Cancer Research.

TET1 and TDG suppress inflammatory response in intestinal tumorigenesis: implications for colorectal tumors with the CpG Island Methylator Phenotype.

V. Moreno, J. Issa, J. Jelinek, 2023, Gastroenterology.

Electronic profiling of membrane antigen expression via immunomagnetic cell manipulation.

A. F. Sarioglu, C. Paweletz, R. Kamm, 2019, Lab on a chip.

A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

Monika S. Kowalczyk, A. Regev, P. Sorger, 2018, Cell.

Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer

M. Salido, F. Rojo, J. Albanell, 2013, Clinical Cancer Research.

ALK status in a primary lung tumour and metachronous metastases

F. Solé, M. Salido, F. Rojo, 2012, Histopathology.

Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

Henry W. Long, M. Dowsett, Jia-Ren Lin, 2023, Cancer research.